Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis

We reviewed the clinical results of a dendritic cell-based phase II clinical vaccine trial in stage IV melanoma and analyzed a patient subgroup treated with standard therapies after stopping vaccination. From 2003 to 2009, 24 metastatic melanoma patients were treated with mature dendritic cells puls...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridolfi, Laura, Petrini, Massimiliano, Fiammenghi, Laura, Granato, Anna Maria, Ancarani, Valentina, Pancisi, Elena, Scarpi, Emanuela, Guidoboni, Massimo, Migliori, Giuseppe, Sanna, Stefano, Tauceri, Francesca, Verdecchia, Giorgio Maria, Riccobon, Angela, Ridolfi, Ruggero
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948909/
https://www.ncbi.nlm.nih.gov/pubmed/20936106
http://dx.doi.org/10.1155/2010/504979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948909/
https://www.ncbi.nlm.nih.gov/pubmed/20936106
http://dx.doi.org/10.1155/2010/504979

Ejemplares similares